Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Darrin J. Bast"'
Publikováno v:
FEMS Immunology & Medical Microbiology. 51:547-554
Streptococcus iniae causes invasive disease and death in fish, and to a lesser extent, sporadic cases of soft-tissue infections in humans. A two-component system termed sivS/R, which regulates capsule expression, was previously identified and charact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d1e6db68a29d6c822189a06d142b532
https://doi.org/10.1111/j.1574-695x.2007.00334.x
https://doi.org/10.1111/j.1574-695x.2007.00334.x
Publikováno v:
Infection and Immunity. 75:5011-5017
Streptococcus pyogenes is a ubiquitous and versatile pathogen that causes a variety of infections with a wide range of severity. The versatility of this organism is due in part to its capacity to regulate virulence gene expression in response to the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c66f40865c63af3c4502ee8a5dc4255e
https://doi.org/10.1128/iai.01824-06
https://doi.org/10.1128/iai.01824-06
Publikováno v:
FEMS Immunology & Medical Microbiology. 50:366-374
Streptococcus iniae causes disease in fish and humans and the presence of capsule is associated with virulence. Tn917 transposon mutagenesis was performed to identify capsule-associated genes and a mutant was isolated, with an insertion in a genetic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4eaeecde66f65babf018a359e0b19a94
https://doi.org/10.1111/j.1574-695x.2007.00261.x
https://doi.org/10.1111/j.1574-695x.2007.00261.x
Autor:
Dennis G. Cvitkovitch, Joyce C. S. de Azavedo, Peter Chang, Kowthar Y. Salim, Martin Handfield, Jeffrey D. Hillman, Darrin J. Bast
Publikováno v:
Infection and Immunity. 73:6026-6038
Group A Streptococcus (GAS) causes a range of diseases in humans, from mild noninvasive infections to severe invasive infections. The molecular basis for the varying severity of disease remains unclear. We identified genes expressed during invasive d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d56ebf7659d1b9f2f12ce5dfea9e65f0
https://doi.org/10.1128/iai.73.9.6026-6038.2005
https://doi.org/10.1128/iai.73.9.6026-6038.2005
Publikováno v:
Journal of Antimicrobial Chemotherapy. 54:424-428
OBJECTIVE: Long-term therapy for anthrax might induce antimicrobial resistance in Bacillus anthracis. The aim of the present study was to investigate the potential of 18 different antibiotics to select resistant isolates of B. anthracis, (ST-1 and St
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ce3b780bd608f6b8b282d4d921e6ea9
https://doi.org/10.1093/jac/dkh258
https://doi.org/10.1093/jac/dkh258
Autor:
Galia Rahav, Carla Duncan, Joyce C. S. de Azavedo, Ethan Rubinstein, Darrin J. Bast, Abed Athamna, David J. Farrell, Donald E. Low
Publikováno v:
Journal of Antimicrobial Chemotherapy. 54:90-94
Received 20 January 2004; returned 9 March 2004; revised 19 April 2004; accepted 21 April 2004Objectives: To identify and characterize the mechanisms of high-level fluoroquinolone resistancein two strains of Bacillus anthracis following serial passa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe26ada084caa4f41d67ed58d8a9a688
https://doi.org/10.1093/jac/dkh294
https://doi.org/10.1093/jac/dkh294
Autor:
M. Massalha, Darrin J. Bast, B. Medlej, Ethan Rubinstein, A. Nura, Muhammad Athamna, A. Athamna, Itzhak Ofek
Publikováno v:
Journal of Antimicrobial Chemotherapy. 53:247-251
OBJECTIVES To investigate the in vitro acquisition of resistance to antibiotics by Bacillus anthracis. METHODS The in vitro activities of 18 antibacterial agents against two strains of B. anthracis, the Sterne strain and the Russian anthrax vaccine s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6a677d71b65bd32c21710a3d73e75aa
https://doi.org/10.1093/jac/dkh016
https://doi.org/10.1093/jac/dkh016
Publikováno v:
Emerging Infectious Diseases
Scopus-Elsevier
Emerging Infectious Diseases, Vol 9, Iss 7, Pp 833-837 (2003)
Scopus-Elsevier
Emerging Infectious Diseases, Vol 9, Iss 7, Pp 833-837 (2003)
The emergence of Streptococcus pneumoniae resistance to β-lactam and macrolide antimicrobial agents has led to recommendations that fluoroquinolones with increased activity against S. pneumoniae, such as levofloxacin, moxifloxacin, and gatifloxacin,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::699624885b51d526db34eda2c1165435
http://europepmc.org/articles/PMC3023429
http://europepmc.org/articles/PMC3023429
Autor:
Michel Laverdière, Allison McGeer, Ross J. Davidson, C. Restieri, Richard Gauthier, Darrin J. Bast, Karl Weiss, Laurie Kilburn, Joyce C. S. de Azavedo, Donald E. Low
Publikováno v:
Clinical Infectious Diseases. 33:517-522
Over the course of a 20-month period, in a hospital respiratory ward in which ciprofloxacin was often used as empirical antimicrobial therapy for lower respiratory tract infections (LRTIs), 16 patients with chronic bronchitis developed nosocomial LRT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa9b65f986f5bd98320c6093e032c936
https://doi.org/10.1086/322658
https://doi.org/10.1086/322658
Publikováno v:
Antimicrobial Agents and Chemotherapy. 45:1911-1914
To determine if susceptibility testing of Streptococcus pneumoniae could detect those isolates that had one of the recognized mechanisms of fluoroquinolone resistance, 101 isolates were selected; the levofloxacin MIC for 28 of these isolates was ≥4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b409abd2f430d092faf5e96a67839423
https://doi.org/10.1128/aac.45.6.1911-1914.2001
https://doi.org/10.1128/aac.45.6.1911-1914.2001